Back to results
TerminatedPhase 3

Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo

NCT01900665

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Xenoscience

Phoenix, Arizona, United States

+197 additional locations

View on ClinicalTrials.gov
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo — TrialFind